期刊文献+

血浆脑利钠肽水平在慢性心力衰竭患者的临床诊断价值研究

The study of diagnostic value about plasma brain natriuretic peptide level in chronic heart failure
原文传递
导出
摘要 目的探讨血浆脑利钠肽水平在慢性心力衰竭患者的临床诊断价值,以为慢性心力衰竭的诊断提供更为可靠有效的规律与依据。方法选取2007年8月至2009年3月于本院治疗的56例慢性心力衰竭患者为研究对象,将其根据NYHA分级分为A组和B组各28例,后选取同期的健康人30例为对照组C组,对三组人员测量血浆脑利钠肽,后将三组水平进行比较分析。且与同期的超声心动图结果进行比较。结果经比较分析,笔者发现三组水平之中,A、B两组明显高于C组,P〈0.01,差异有统计学意义,而A组与B组比较,P〈0.05,差异有统计学意义。结论通过研究比较发现,血浆脑利钠肽水平在慢性心力衰竭患者的临床诊断价值较高,可为慢性心力衰竭的诊断提供更为可靠有效的规律与依据,值得临床进一步研究探讨。 Objective To study the diagnostic value about plasma brain natriuretic peptide level in chronic heart failure in order to provide evidence for the diagnostic about chronic heart failure. Methods 56 examples with chronic heart failure patients from August 2007 to March 2009 in my courtyard treatment were divided into A group(28 examples)and B group(28 examples)based on NYHA. 50 normal healthy person examples were selected as the control group ( C group). The plasma brain natriuretic peptide level of the three groups were compared and studied. Results After the comparative study, we found that the plasma brain natriuretic peptide level of A group and B group was higher that of C group,P 〈0. 01 ,there was significant difference between thethree group. And the plasma brain natriuretic peptide level between the A group and B group were compared,P 〈 0. 05, the difference has statistical significance. Conclusion The diagnostic value about plasma brain natriuretic peptide level in chronic heart failure was obviously bigger. It can provide evidence for the diagnostic about chronic heart failure, and is worth further studying.
出处 《中国临床实用医学》 2010年第2期29-30,共2页 China Clinical Practical Medicine
关键词 血浆脑利钠肽水平 慢性心力衰竭 诊断价值 Plasma brain natriuretic peptide level Chronic heart failure Diagnostic value
  • 相关文献

参考文献8

  • 1Packer M;Cohn JN;Abraham WT.Consensus recommendations for the management of chronic heart failure,1999(2A).
  • 2张晖,邓南伟,戚秀卿,罗明,邓兵.内皮功能不全在心衰中的作用[J].同济大学学报(医学版),2001,22(4):22-25. 被引量:15
  • 3Gupta RC;Imai M;Jiang AJ.Chronic Therapy with Selective Electric Vagus Nerve Stimulation Normalizes Plasma Concentration of Tissue Necrosis Factor-α,Interleukin-6 and B-Type Natriuretic Peptide in Dogs with Heart Failure,2006(06).
  • 4上海市心力衰竭调查协作组.上海市1980、1990、2000年心力衰竭住院患者流行病学及治疗状况调查[J].中华心血管病杂志,2002,30(1):24-27. 被引量:195
  • 5中华人民共和国卫生部.中药新药治疗心力衰竭的临床研究指导原则,2002.
  • 6Alonso-Martinez JL;Llorente-Diez B;Echegaray-Agara M.Creactive protein as a predictor of improvement and readmission in heart failure[J],2002(03).
  • 7胡大一;马长生.心脏病学实践2005-新进展与临床案例,2005.
  • 8Swedlberg K;Cleland J;Dargie H.Guidelines for the diagnosis and treatment of chronic heart failure:executive summary (update 2005):The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology,2005(11).

二级参考文献13

  • 1陈伯銮.一氧化氮的生物效应与临床的应用[J].中国急救医学,1995,15(3):50-54. 被引量:14
  • 2Cleland JG, Clark A. Has the survival of the heart failure population changed? Lessons from trials. Am J Cardiol, 1999,83:112D-119D.
  • 3Massie BM, Shah NB. Evolving trends in the epidemiologic factors of heart failure: rationale for preventive strategies and comprehensive disease management. Am Heart J, 1997,133:703-712.
  • 4Gary R, Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. JAMA, 1995,273:1450-1456.
  • 5Cleland JG, Swedberg K, Poole-Wilson PA. Successes and failures of current treatment of heart failure. Lancet, 1998,352:19-28.
  • 6Narang R, Cleland JG, Erhardt L, et al. Mode of death in chronic heart failure: a request for more accurate classification. Eur Heart J, 1996,17:1390-1403.
  • 7Pierpont GL, Cohn JN, Franciosa JA. Combined oral hydralazine-nitrate therapy in left ventricular failure. Hemodynamic equivalency to sodium nitroprusside. Chest, 1978,73:8-13.
  • 8Jugdutt BI, Khan MI. Effect of prolonged nitrate therapy on left ventricular remodeling after canine myocardial infarction. Circulation, 1994,89:2297-2307.
  • 9Packer M, O′Connor CM, Ghali JK, et al. Effect of amlodipine on morbidity and mortality in servere chronic heart failure. N Engl J Med, 1996,335:1107-1114.
  • 10Cohn JN, Ziesche S, Smith R, et al. Effect of the calcium antagonist felodipine as supplementary vasodilator therapy in patients with chronic heart failure treated with enalapril: V-Heft III. Circulation, 1997,96:856-863.

共引文献209

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部